IP Library Granted Patent US 9,861,759
Granted Patent B2
US 9,861,759 · App. 13/964,651 · Granted Jan 9, 2018

External drug pump

Inventors: Yossi Gross (Moshav Mazor, IL); Oz Cabiri (Macabim-Reut, IL)
Assignee: MEDIMOP MEDICAL PROJECTS LTD.
A61M5/31596A61M5/1452A61M5/1456A61M5/14248A61M5/14566A61M5/158A61M5/172F16H25/12A61M5/1413A61M5/16827A61M5/1723A61M5/3146A61M2005/1426A61M2005/14252A61M2005/14268A61M2005/14533A61M2005/31518A61M2205/3523A61M2205/3569Y10T74/18576
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,759
App. No.
13/964,651
Granted
Jan 9, 2018
Kind
B2
Abstract

Apparatus is described for administering a substance to a subject. A vial contains the substance and a stopper is disposed within the vial and is slidably coupled to the vial. A first threaded element is (a) rotatable with respect to the vial and (b) substantially immobile proximally with respect to the vial during rotation of the first threaded element. A second threaded element is threadedly coupled to the first threaded element. At least a distal end of the second threaded element is substantially non-rotatable with respect to the vial, and the distal end of the second threaded element defines a coupling portion that couples the second threaded element to the stopper. The first threaded element, by rotating, linearly advances the stopper and at least the distal end of the second threaded element toward a distal end of the vial. Other embodiments are also described.

Claims (14)

1. An activation mechanism for a drug delivery device wearable by a patient, the activation mechanism comprising:

a base having a patient contact surface;

a hollow sleeve disposed on the base, the hollow sleeve having first and second ends and extending along a longitudinal axis between the first and second ends, the hollow sleeve having a holding portion, the holding portion extending generally longitudinally from the first end of the sleeve, the holding portion having a retaining surface arranged opposite to the first end of the sleeve, the retaining surface facing the patient contact surface of the base and extending generally perpendicularly with respect to the longitudinal axis, the retaining surface being positioned between the first end of the sleeve and the patient contact surface of the base;

a longitudinally extending needle having a sharp end and an opposed end;

a needle holder coupled to the opposed end of the needle and being movable along the longitudinal axis with respect to the sleeve between a withdrawn position, wherein the sharp end of the needle is disposed within the base, and an injection position, wherein the sharp end of the needle extends beyond the patient contact surface of the base;

a spring coupled to the needle holder and biasing the needle holder to the withdrawn position;

a longitudinally extending cannula having a free end and being sized to coaxially receive the needle therein;

a cannula holder coupled to the cannula opposite the free end thereof and movable along the longitudinal axis between a retracted position, wherein the free end of the cannula is disposed within the base and at least a portion of the cannula holder is disposed between the first and second ends of the sleeve, and an extended position, wherein the free end of the cannula extends beyond the patient contact surface of the base, and

wherein the retaining surface of the holding portion abuts a generally radially extending ledge of the cannula holder when the needle holder is in the withdrawn position and the cannula holder is in the extended position to prevent relative movement of the cannula holder to the retracted position.

2. The activation mechanism of claim 1 , wherein the spring surrounds at least a portion of the needle.

3. The activation mechanism of claim 1 , wherein when the needle holder is in the withdrawn position, the sharp end of the needle is disposed within the cannula holder.

4. The activation mechanism of claim 1 , wherein the needle holder includes a retention surface that is oriented generally parallel to the patient contact surface and is in contact with the spring.

5. The activation mechanism of claim 1 , wherein a portion of the needle holder is disposed within the cannula holder when the needle holder is in the injection position and the cannula holder is in the extended position.

6. The activation mechanism of claim 1 , wherein a portion of the needle holder is disposed within the cannula holder when the needle holder is in the withdrawn position and the cannula holder is in the retracted position.

Assignments (2)
CHANGE OF NAME Recorded Oct 1, 2019
From: MEDIMOP MEDICAL PROJECTS LTD.
To: WEST PHARMA. SERVICES IL, LTD.
Reel/Frame 050593/0378 →
CHANGE OF NAME Recorded May 3, 2018
From: MEDIMOP MEDICAL PROJECTS LTD
To: WEST PHARMA SERVICES IL, LTD.
Reel/Frame 046075/0392 →
Continuity (3)
Continuation 12244666 · Oct 2, 2008
Provisional Application 60997459 · Oct 2, 2007
Related Publication 20130331791A1 · Dec 12, 2013